Sort
64,565 grants matching “drug discovery”
CHEMICAL GENETIC APPROACHES TO BASIC CELL BIOLOGY
$1,419,990Harvard University (Medical School) · P01 · FY2001 · GM
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$1,419,180Joseph Eric Levitt · Stanford University · UG3 · FY2019 · HL
Molecular diagnosis and outcome prediction in lymphoma
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
High Throughput Screening for Ligands for Seven Transmembrane-spanning Receptors
$1,417,665Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease
$1,417,658Scott Scarneo · Eydis Bio, Inc. · R44 · FY2025 · HL
Discovery of Anticancer Agents of Diverse Natural Origin
$1,417,476Alan Douglas Kinghorn · Ohio State University · P01 · FY2015 · CA
AMP-AD Data Coordination Center
$1,417,076Lara M Mangravite · Sage Bionetworks · U24 · FY2020 · AG
Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center
$1,416,000Mustafa None Sahin · Boston Children'S Hospital · P50 · FY2025 · HD
Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center
$1,416,000Mustafa None Sahin · Boston Children'S Hospital · P50 · FY2024 · HD
Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center
$1,416,000Mustafa None Sahin · Boston Children'S Hospital · P50 · FY2022 · HD
Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center
$1,416,000Mustafa None Sahin · Boston Children'S Hospital · P50 · FY2023 · HD
Activity-dependent probes for spatially-defined proteomics
$1,414,340Christina Kim · University Of California At Davis · DP2 · FY2023 · MH
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$1,414,230Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2014 · LM
Pathogen-specific drug targets for weaponized bacteria
$1,413,978Vincent A. Fischetti · Rockefeller University · U19 · FY2006 · AI
Vascular remodeling in patients with rare genetic disorders
$1,413,751Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2019 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2021 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UG3 · FY2017 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2020 · HL
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,413,657Matthew J Ellis · Baylor College Of Medicine · U01 · FY2018 · CA
A Quantitative Proteomics Platform to Characterize the Nicotine-Dependent Brain
$1,413,284Benjamin F Cravatt · Scripps Research Institute, The · RC2 · FY2010 · DA
Automation and validation of human on a chip systems for drug discovery
$1,412,888Michael L Shuler · Hesperos, Llc · R44 · FY2019 · TR
Pathogen-specific drug targets for weaponized bacteria
$1,412,862Vincent A. Fischetti · Rockefeller University · U19 · FY2007 · AI
Texas Repository for AIDS Neuropathogenesis Research
$1,412,231Benjamin B. Gelman · University Of Texas Med Br Galveston · R24 · FY2007 · NS
Next generation T cell therapies for mutant KRAS solid tumors
$1,412,213Beatriz M. Carreno · University Of Pennsylvania · UG3 · FY2024 · CA